perfosfamide has been researched along with Experimental Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bos, GM; Melief, CJ; Offringa, R; Ooms, M; Vierboom, MP | 1 |
| Colvin, OM; Santos, GW | 1 |
| Berd, D; Maguire, H; Mastrangelo, MJ | 1 |
| Colvin, M; Dray, S; Mokyr, MB | 1 |
2 review(s) available for perfosfamide and Experimental Neoplasms
| Article | Year |
|---|---|
Pharmacological purging of bone marrow with reference to autografting.
Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic | 1986 |
The immunoaugmenting effects of cancer chemotherapeutic agents.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antineoplastic Agents; Cyclophosphamide; Humans; Hypersensitivity, Delayed; Immune Tolerance; Lymphocytes; Mice; Neoplasms; Neoplasms, Experimental; T-Lymphocytes, Regulatory | 1986 |
1 trial(s) available for perfosfamide and Experimental Neoplasms
| Article | Year |
|---|---|
Pharmacological purging of bone marrow with reference to autografting.
Topics: Adolescent; Adult; Animals; Bleomycin; Bone Marrow; Bone Marrow Transplantation; Cell Separation; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Etoposide; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Lysophosphatidylcholines; Methylprednisolone; Neoplasms, Experimental; Phospholipid Ethers; Pyrimidinones; Transplantation, Autologous; Transplantation, Isogeneic | 1986 |
2 other study(ies) available for perfosfamide and Experimental Neoplasms
| Article | Year |
|---|---|
Cyclophosphamide enhances anti-tumor effect of wild-type p53-specific CTL.
Topics: Adjuvants, Immunologic; Adoptive Transfer; Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Immunohistochemistry; Immunotherapy, Adoptive; Interferon-alpha; Interferon-beta; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; ras Proteins; T-Lymphocytes, Cytotoxic; Time Factors; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor.
Topics: Adjuvants, Immunologic; Animals; Cyclophosphamide; Cytotoxicity, Immunologic; Female; Immune Tolerance; Immunization; Mice; Mice, Inbred BALB C; Mitomycin; Mitomycins; Neoplasms, Experimental; Spleen; Thymidine | 1985 |